These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12810830)

  • 1. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
    Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
    Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
    Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
    Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.
    Vannucchi AM; Bosi A; Glinz S; Pacini P; Linari S; Saccardi R; Alterini R; Rigacci L; Guidi S; Lombardini L; Longo G; Mariani MP; Rossi-Ferrini P
    Br J Haematol; 1998 Dec; 103(3):610-7. PubMed ID: 9858208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
    Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
    J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products.
    Zhong XY; Kaul S; Diel I; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 1999; 125(5):286-91. PubMed ID: 10359133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of MUC1 and keratin 19 mRNAs in the bone marrow by quantitative RT-PCR predicts the risk of distant metastasis in breast cancer patients.
    Nogi H; Takeyama H; Uchida K; Agata T; Horiguchi-Yamada J; Yamada H
    Breast Cancer; 2003; 10(1):74-81. PubMed ID: 12525767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA.
    Ikeda N; Miyoshi Y; Motomura K; Inaji H; Koyama H; Noguchi S
    Jpn J Cancer Res; 2000 Sep; 91(9):918-24. PubMed ID: 11011120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
    Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
    Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of cytokeratin 19 in bone marrow of patients with breast cancer].
    Li BJ; Huang XP; Wei WD; Wang JY; Su XD; Zhang X; Hong WS; Tang J; Zhang LJ; Long H; Yang MT; Rong TH
    Ai Zheng; 2005 Jun; 24(6):735-9. PubMed ID: 15946491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.
    Masuda TA; Kataoka A; Ohno S; Murakami S; Mimori K; Utsunomiya T; Inoue H; Tsutsui S; Kinoshita J; Masuda N; Moriyama N; Mori M
    Int J Oncol; 2005 Mar; 26(3):721-30. PubMed ID: 15703829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
    Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
    Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of bone marrow micrometastases of breast tumors].
    Dubecz S; Csuka O; Török K; Vasas N; Péley G; Doleschal Z; Sulyok Z; Láng I; Köves I
    Magy Seb; 2003 Aug; 56(3-4):108-12. PubMed ID: 14619093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
    Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of detecting lymph node micrometastasis of colorectal cancer by reverse transcriptase-polymerase chain reaction (RT-PCR)].
    Yuan HY; Cheng FL; Wei ZZ; Yang GL; Chen JK
    Ai Zheng; 2004 Sep; 23(9):1069-73. PubMed ID: 15363204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.